Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
Next >
Why Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week
July 08, 2022
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
Market News
EDIT
BLUE
From
Motley Fool
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
Tickers
EDIT
NTLA
Tags
Briefs
EDIT
News
From
Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
June 07, 2022
Tickers
ADVM
AIKI
DCTH
DNA
Tags
Coronavirus
IMTX
Benzinga
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 07, 2022
Tickers
AIKI
BAOS
BCAN
CETX
Tags
AIKI
Today's Market
EDIT
From
InvestorPlace
16 Stocks Moving in Tuesday's Pre-Market Session
June 07, 2022
Tickers
AERC
AUVI
BCAN
CETX
Tags
CETX
AERC
Market News
From
Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
June 02, 2022
Tickers
ARKG
ARKK
BNR
DNA
Tags
Market News
NYSEARCA:ARKK,NYSEARCA:ARKG,NASDAQ:IONS,NASDAQ:BNR,NYSE:DNA,NASDAQ:EDIT
DNA
From
InvestorPlace
Editas Medicine's Return On Capital Employed Insights
May 19, 2022
Tickers
EDIT
Tags
Benzinga
EDIT
Earnings
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
CRSP
Recent Press Releases
^IXIC
From
Motley Fool
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Tickers
BBIO
BFRI
BMY
BTTX
Tags
GNHAY
CSLLY
News
From
Benzinga
These 5-Stock Samplers Have Gotten Whacked. And That's OK
May 13, 2022
Tickers
AAPL
ABNB
AMGN
AMZN
Tags
BLUE
PTON
AMZN
From
Motley Fool
Expert Ratings for Editas Medicine
May 09, 2022
Tickers
EDIT
Tags
EDIT
Analyst Ratings
Market News
From
Benzinga
Editas Medicine: Q1 Earnings Insights
May 04, 2022
Tickers
EDIT
Tags
Earnings
News
EDIT
From
Benzinga
Editas Medicine Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
EDIT
Tags
Market News
Benzinga
Earnings
From
Benzinga
Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia
April 26, 2022
Tickers
EDIT
Tags
Market News
FDA
Benzinga
From
Benzinga
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
Market News
EDIT
NTLA
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
Recent Press Releases
CRSP
VRTX
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
JSDA
N
AMZN
From
Motley Fool
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
March 01, 2022
Tickers
EDIT
Tags
Legal
General
Movers
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
AMRS
JAZZ
RGNX
From
Benzinga
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
Tickers
AREB
ATXI
AVGR
AVIR
Tags
Small Cap
LCID
AREB
From
Benzinga
Expert Ratings For Editas Medicine
February 25, 2022
Tickers
EDIT
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers
ABCL
ADGI
AGIO
ARYD
Tags
General
TMDX
MMSI
From
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
PODD
VIR
FLGT
From
Benzinga
51 Biggest Movers From Yesterday
February 09, 2022
Tickers
AA
ALJJ
AMZN
ANGH
Tags
AA
NXTP
CYRN
From
Benzinga
Editas Suddenly Terminates Chief Medical Officer Without An Explanation
February 08, 2022
Tickers
EDIT
Tags
why it's moving
News
EDIT
From
Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
February 08, 2022
Tickers
AA
AMZN
ANGH
ANY
Tags
AREB
Trading Ideas
GM
From
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Tickers
ALKS
AMGN
AXSM
BIIB
Tags
HAE
BIIB
INSP
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 08, 2022
Tickers
ACHV
ATHE
ATNF
EDIT
Tags
ATHE
Top Gainers
ACHV
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 08, 2022
Tickers
AEYE
AMZN
ANGH
AREB
Tags
TNXP
LGHL
PTON
From
InvestorPlace
21 Stocks Moving in Tuesday's Pre-Market Session
February 08, 2022
Tickers
AMZN
ANY
AREB
ATHE
Tags
Small Cap
GM
EYES
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.